Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma
NCT02489838 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2020-06-11
Summary
To Calculate the amount radiation the lung receives in patients receiving Yttrium-90 for Liver Cancer.
Conditions
- Liver Neoplasms
Sponsors & Collaborators
-
Alan Katz
lead OTHER
Principal Investigators
-
Alan Katz, MD · Universtiy of Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-03
- Primary Completion
- 2019-08-07
- Completion
- 2019-08-07
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy in Treating Patients With Liver Metastases
NCT00255814 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT01899261 ·Status: COMPLETED ·Phase: NA
-
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System
NCT03889093 ·Status: TERMINATED ·Phase: NA
-
Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
NCT01201096 ·Status: UNKNOWN
-
Individualized Stereotactic Body Radiotherapy of Liver Metastases
NCT01239381 ·Status: COMPLETED ·Phase: NA
-
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
NCT00976898 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
NCT03812289 ·Status: TERMINATED ·Phase: NA
-
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
NCT00154817 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00777894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dynamic Contrast Enhanced HCC SABR Liver Study
NCT02847767 ·Status: UNKNOWN ·Phase: NA
-
The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy
NCT00774501 ·Status: COMPLETED ·Phase: NA
-
Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres
NCT05227482 ·Status: UNKNOWN ·Phase: PHASE2
-
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
NCT00466856 ·Status: TERMINATED ·Phase: PHASE2
-
Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry
NCT02582034 ·Status: COMPLETED ·Phase: PHASE2
-
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
NCT02683200 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
NCT06362395 ·Status: RECRUITING ·Phase: PHASE3
-
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
NCT02721056 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiotherapy for Liver Tumors
NCT01347333 ·Status: COMPLETED ·Phase: NA
-
Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma
NCT06595108 ·Status: RECRUITING ·Phase: NA
-
Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
NCT06355895 ·Status: RECRUITING ·Phase: NA
-
Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy
NCT01850316 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
NCT00178243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
NCT06725121 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System
NCT00026871 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC
NCT03199807 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2